ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.

Author Information

Badreddin Edris, Inigo Espinosa, Thomas Muhlenberg, Amanda Mikels, Cheng-Han Lee, Sonja E Steigen, Shirley Zhu, Kelli D Montgomery, Alexander JF Lazar, Dina Lev, Jonathan A Fletcher, Andrew H Beck, Robert B West, Roel Nusse and Matt van de Rijn

Department of Pathology, Stanford University School of Medicine, CA, USA; Department of Genetics, Stanford University School of Medicine, CA, USA

Publication